gentamicin has been researched along with Pelvic Inflammatory Disease in 41 studies
Gentamicins: A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.
Pelvic Inflammatory Disease: A spectrum of inflammation involving the female upper genital tract and the supporting tissues. It is usually caused by an ascending infection of organisms from the endocervix. Infection may be confined to the uterus (ENDOMETRITIS), the FALLOPIAN TUBES; (SALPINGITIS); the ovaries (OOPHORITIS), the supporting ligaments (PARAMETRITIS), or may involve several of the above uterine appendages. Such inflammation can lead to functional impairment and infertility.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The pharmacokinetics (PK) of isepamicin were studied in 8 febrile neutropenic patients with hematologic malignancy and in 20 young women with acute pelvic inflammatory disease (PID)." | 9.11 | Key pharmacokinetic parameters of isepamicin in febrile neutropenic cancer patients and in women with acute pelvic inflammatory disease. ( Gala, JL; Leal, T; Vandercam, B; Wallemacq, P; Yombi, JC, 2005) |
| "Ampicillin-sulbactam is as effective and well tolerated as combination regimens using cefoxitin plus doxycycline and clindamycin plus-gentamicin for the treatment of pelvic inflammatory disease or endometritis, respectively." | 9.07 | Randomized comparison of ampicillin-sulbactam to cefoxitin and doxycycline or clindamycin and gentamicin in the treatment of pelvic inflammatory disease or endometritis. ( Crombleholme, WR; Gibbs, RS; McGregor, JA; Newton, E; Sweet, RL; Tuomala, R, 1994) |
| "The clinical efficacy and safety of clindamycin-gentamicin versus doxycycline-cefoxitin in the treatment of acute pelvic inflammatory disease was evaluated in a comparative, randomized, prospective, multicenter study." | 9.07 | Comparative evaluation of clindamycin/gentamicin and cefoxitin/doxycycline for treatment of pelvic inflammatory disease: a multi-center trial. The European Study Group. ( , 1992) |
| "A prospective, randomized, controlled, non-blind clinical trial was conducted to compare the efficacy of monotherapy with ciprofloxacin with that of a combination of clindamycin plus gentamicin in the treatment of patients with acute pelvic inflammatory disease." | 9.06 | Efficacy of single-agent therapy for the treatment of acute pelvic inflammatory disease with ciprofloxacin. ( Crombleholme, WR; Luft, J; Ohm-Smith, M; Schachter, J; Sweet, RL; Whidden, R, 1989) |
| "Patients with uncomplicated pelvic inflammatory disease (PID) (acute salpingitis and no pelvic masses) were randomly assigned for treatment with either cefotaxime or cefoxitin." | 9.06 | Comparison of cefotaxime, cefoxitin and clindamycin plus gentamicin in the treatment of uncomplicated and complicated pelvic inflammatory disease. ( Faro, S; Hammill, H; LaPread, E; Maccato, M; Martens, MG; Riddle, GD, 1990) |
| "In this prospective trial, 130 hospitalized patients with acute pelvic inflammatory disease based on clinical criteria were randomly treated with intravenous gentamicin plus clindamycin (N = 63) or cefoxitin plus doxycycline (N = 67) for at least 4 days, followed by oral clindamycin or doxycycline, respectively, for a total of 14 days." | 9.06 | A randomized comparison of gentamicin-clindamycin and cefoxitin-doxycycline in the treatment of acute pelvic inflammatory disease. ( Gibbs, RS; Walters, MD, 1990) |
| "60 hospitalized patients with pelvic inflammatory disease entered a randomised study to compare the therapeutic efficacy and tolerability of parenteral sulbactam/ampicillin with that of clindamycin/gentamicin." | 9.06 | A comparison of parenteral sulbactam/ampicillin versus clindamycin/gentamicin in the treatment of pelvic inflammatory disease. ( Gunning, J, 1986) |
| " Piperacillin sodium was compared with a combination of clindamycin and gentamicin as therapy for 63 female patients who were hospitalized with acute pelvic infections including pelvic abscess complicating community acquired salpingitis." | 9.06 | Piperacillin and a combination of clindamycin and gentamicin for the treatment of hospital and community acquired acute pelvic infections including pelvic abscess. ( Heard, MC; Hemsell, DL; Hemsell, PG; Nobles, BJ, 1987) |
| "Gentamicin in combination with other antibiotics is frequently used in the treatment of postpartum endomyometritis." | 7.68 | Serum gentamicin concentrations in postpartum endomyometritis. ( Letterie, GS, 1992) |
| "The aim of the present clinical study was to evaluate the therapeutic effectiveness of two different antibiotic combinations (piperacillin + erythromycin and piperacillin + clindamycin + gentamycin) in the medical treatment of patients with pelvic inflammatory disease, respectively at the II and III stage." | 7.68 | [Medical treatment of pelvic inflammatory disease. A clinical study on the therapeutic effectiveness of piperacillin + erythromycin and of piperacillin + clindamycin + gentamycin]. ( Farnè, C; Piccione, E; Sesti, F, 1990) |
| "Acute pelvic inflammatory disease is associated with significant adverse reproductive sequelae." | 5.28 | Sulbactam/ampicillin in the treatment of acute pelvic inflammatory disease. ( Crombleholme, WR; Landers, DV; Schachter, J; Sweet, RL, 1989) |
| "The pharmacokinetics (PK) of isepamicin were studied in 8 febrile neutropenic patients with hematologic malignancy and in 20 young women with acute pelvic inflammatory disease (PID)." | 5.11 | Key pharmacokinetic parameters of isepamicin in febrile neutropenic cancer patients and in women with acute pelvic inflammatory disease. ( Gala, JL; Leal, T; Vandercam, B; Wallemacq, P; Yombi, JC, 2005) |
| "The aim of this presentation is to study the advantages and disadvantages of perioperative prophylaxis with the antibiotic Mefoxin against the classical postoperative antibiotic prophylaxis with penicillin and gentamicine, as well as to analyse the place of this antibiotic in modern treatment of different forms of pelvic inflammatory disease." | 5.08 | [The use of the antibiotic cefoxitin (Mefoxin) in gynecological practice]. ( Popov, I; Stoĭkov, S, 1997) |
| "Ampicillin-sulbactam is as effective and well tolerated as combination regimens using cefoxitin plus doxycycline and clindamycin plus-gentamicin for the treatment of pelvic inflammatory disease or endometritis, respectively." | 5.07 | Randomized comparison of ampicillin-sulbactam to cefoxitin and doxycycline or clindamycin and gentamicin in the treatment of pelvic inflammatory disease or endometritis. ( Crombleholme, WR; Gibbs, RS; McGregor, JA; Newton, E; Sweet, RL; Tuomala, R, 1994) |
| "The clinical efficacy and safety of clindamycin-gentamicin versus doxycycline-cefoxitin in the treatment of acute pelvic inflammatory disease was evaluated in a comparative, randomized, prospective, multicenter study." | 5.07 | Comparative evaluation of clindamycin/gentamicin and cefoxitin/doxycycline for treatment of pelvic inflammatory disease: a multi-center trial. The European Study Group. ( , 1992) |
| "Patients with uncomplicated pelvic inflammatory disease (PID) (acute salpingitis and no pelvic masses) were randomly assigned for treatment with either cefotaxime or cefoxitin." | 5.06 | Comparison of cefotaxime, cefoxitin and clindamycin plus gentamicin in the treatment of uncomplicated and complicated pelvic inflammatory disease. ( Faro, S; Hammill, H; LaPread, E; Maccato, M; Martens, MG; Riddle, GD, 1990) |
| "60 hospitalized patients with pelvic inflammatory disease entered a randomised study to compare the therapeutic efficacy and tolerability of parenteral sulbactam/ampicillin with that of clindamycin/gentamicin." | 5.06 | A comparison of parenteral sulbactam/ampicillin versus clindamycin/gentamicin in the treatment of pelvic inflammatory disease. ( Gunning, J, 1986) |
| "A prospective, randomized, controlled, non-blind clinical trial was conducted to compare the efficacy of monotherapy with ciprofloxacin with that of a combination of clindamycin plus gentamicin in the treatment of patients with acute pelvic inflammatory disease." | 5.06 | Efficacy of single-agent therapy for the treatment of acute pelvic inflammatory disease with ciprofloxacin. ( Crombleholme, WR; Luft, J; Ohm-Smith, M; Schachter, J; Sweet, RL; Whidden, R, 1989) |
| "In this prospective trial, 130 hospitalized patients with acute pelvic inflammatory disease based on clinical criteria were randomly treated with intravenous gentamicin plus clindamycin (N = 63) or cefoxitin plus doxycycline (N = 67) for at least 4 days, followed by oral clindamycin or doxycycline, respectively, for a total of 14 days." | 5.06 | A randomized comparison of gentamicin-clindamycin and cefoxitin-doxycycline in the treatment of acute pelvic inflammatory disease. ( Gibbs, RS; Walters, MD, 1990) |
| " Piperacillin sodium was compared with a combination of clindamycin and gentamicin as therapy for 63 female patients who were hospitalized with acute pelvic infections including pelvic abscess complicating community acquired salpingitis." | 5.06 | Piperacillin and a combination of clindamycin and gentamicin for the treatment of hospital and community acquired acute pelvic infections including pelvic abscess. ( Heard, MC; Hemsell, DL; Hemsell, PG; Nobles, BJ, 1987) |
| "The efficacy and safety of two antibiotic combination (clindamycin + gentamycin [C + G] versus metronidazole + gentamycin [M + G]) have been compared in 45 in-patients suffering from pelvic inflammatory disease in a clinical prospective randomized trial." | 5.06 | [Prospective randomized study comparing the efficacy and tolerance of clindamycin-gentamycin versus metronidazole-gentamycin in acute utero-adnexal infections in hospitalized patients]. ( Cacault, JA; Engelman, P; Lebceuf, D; Rousset, D, 1987) |
| "Eighteen patients with serious Bacteroides infections were treated with systemic clindamycin-2-phosphate." | 5.04 | Treatment of Bacteroides infection with clindamycin-2-phosphate. ( Dickinson, PC; Saphyakhajon, P, 1974) |
| "To compare the rates of cure of septic abortion and pelvic inflammatory disease using a daily dose of clindamycin with gentamicin versus divided doses, we conducted a retrospective cohort study, where the electronic records of 661 patients who used clindamycin 1 × , 3 × or 4 ×/day (groups 1, 3 and 4, respectively) between September 2002 and August 2010 were analysed." | 3.79 | Daily dose of clindamycin versus standard divided doses in obstetrical and gynecological infections: a retrospective cohort study. ( Fuhrich, DG; Giugno, CS; Gonçalves, KG; Rabaioli, PS; Sartor, NC; Savaris, RF; Silva, AL, 2013) |
| "The aim of the present clinical study was to evaluate the therapeutic effectiveness of two different antibiotic combinations (piperacillin + erythromycin and piperacillin + clindamycin + gentamycin) in the medical treatment of patients with pelvic inflammatory disease, respectively at the II and III stage." | 3.68 | [Medical treatment of pelvic inflammatory disease. A clinical study on the therapeutic effectiveness of piperacillin + erythromycin and of piperacillin + clindamycin + gentamycin]. ( Farnè, C; Piccione, E; Sesti, F, 1990) |
| "Gentamicin in combination with other antibiotics is frequently used in the treatment of postpartum endomyometritis." | 3.68 | Serum gentamicin concentrations in postpartum endomyometritis. ( Letterie, GS, 1992) |
| " In the present study, piperacillin was compared with a combination of clindamycin and gentamicin for the treatment of 83 women with pelvic infection (42 with endometritis, 29 with posthysterectomy cuff infections, 11 with acute salpingitis, and one with a wound infection)." | 3.67 | Piperacillin versus clindamycin plus gentamicin for pelvic infections. ( Connor, KD; Gibbs, RS; Gilstrap, LC; Maier, RC; St Clair, PJ, 1984) |
| "The serum half-life of gentamicin following an intravenous dose was compared between 19 pregnant women (28-34 weeks of pregnancy) with premature rupture of the membranes and 17 non-pregnant women with pelvic inflammatory disease, the groups being age and weight matched." | 3.67 | Gentamicin serum half-life: a comparison between pregnant and non-pregnant women. ( Amoday, I; Aviram, A; Hezroni, Y; Lazebnik, N; Lazebnik, R; Noy, S, 1985) |
| "48 patients with acute pelvic inflammatory diseases (35 cases of acute adnexitis and 13 cases of inflammatory adnexal tumours) were treated with an antibiotic combination of Ampicillin/Oxacillin and Sisomicin." | 3.66 | [Treatment of acute pelvic inflammatory diseases with a new antibiotic compound preparation (author's transl)]. ( Burmucic, R, 1980) |
| "30 patients had severe acute pelvic inflammatory disease with peritonitis, 3 tubo-ovarian abscesses, 4 endomyometritis, and 2 posthysterectomy pelvic cellulitis." | 2.66 | Sulbactam/ampicillin versus metronidazole/gentamicin in the treatment of severe pelvic infections. ( Crombleholme, W; Dahrouge, D; DeKay, V; Hadley, WK; Landers, D; Ohm-Smith, M; Robbie, MO; Sweet, RL, 1986) |
| "Forty-four patients with severe pelvic inflammatory disease were randomly divided into two groups." | 2.66 | [The drug combination amoxicillin-clavulanic acid compared to the triple combination ampicillin-gentamicin-metronidazole in the treatment of severe adnexal infections]. ( Barrier, J; Bercau, G; Ciraru-Vigneron, N; Felten, A; Leaute, JB; Nguyen Tan Lung, R; Sauvanet, E; Zylbertrest, T, 1986) |
| "Penicillin G was added for the coverage of enterococci." | 2.66 | Piperacillin alone vs triple antibiotic combination in gynecological infections. ( Acar, B; Zissis, NP, 1989) |
| "Clinical diagnoses included pelvic inflammatory disease (53), endomyometritis after cesarean section (24), and cellulitis following gynecological surgery (14)." | 2.66 | Comparison of cefoxitin and clindamycin-gentamicin for pelvic infections. ( Grossman, JH; Larsen, JW; Voise, CT, 1986) |
| "Acute pelvic inflammatory disease is associated with significant adverse reproductive sequelae." | 1.28 | Sulbactam/ampicillin in the treatment of acute pelvic inflammatory disease. ( Crombleholme, WR; Landers, DV; Schachter, J; Sweet, RL, 1989) |
| "Sixty Jordanian women with pelvic inflammatory disease (PID) were studied." | 1.28 | Amoxycillin/clavulanic acid (augmentin) compared with triple drug therapy for pelvic inflammatory disease. ( Barakat, HF; Dajani, YF; Masoud, AA; Sartawi, SA; Uri, FI, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (46.34) | 18.7374 |
| 1990's | 18 (43.90) | 18.2507 |
| 2000's | 2 (4.88) | 29.6817 |
| 2010's | 2 (4.88) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giugno, CS | 1 |
| Silva, AL | 1 |
| Fuhrich, DG | 1 |
| Rabaioli, PS | 1 |
| Gonçalves, KG | 1 |
| Sartor, NC | 1 |
| Savaris, RF | 1 |
| Yeh, YH | 1 |
| Wang, PH | 1 |
| Lin, LY | 1 |
| Tee, YT | 1 |
| Chou, MC | 1 |
| Yang, SF | 1 |
| Tsai, HT | 1 |
| Yombi, JC | 1 |
| Wallemacq, P | 1 |
| Leal, T | 1 |
| Gala, JL | 1 |
| Vandercam, B | 1 |
| Yao, XQ | 1 |
| Yang, HE | 1 |
| Gilstrap, LC | 1 |
| Maier, RC | 1 |
| Gibbs, RS | 3 |
| Connor, KD | 1 |
| St Clair, PJ | 1 |
| Thompson, SE | 1 |
| Hager, WD | 1 |
| Wong, KH | 1 |
| Lopez, B | 1 |
| Ramsey, C | 1 |
| Allen, SD | 1 |
| Stargel, MD | 1 |
| Thornsberry, C | 1 |
| Benigno, BB | 1 |
| Thompson, JD | 1 |
| Shulman, JA | 1 |
| Drugan, A | 1 |
| Itskovitz, J | 1 |
| Fisher, M | 1 |
| Brandes, JM | 1 |
| Weinstein, L | 1 |
| Burmucic, R | 1 |
| Hemsell, DL | 3 |
| Little, BB | 1 |
| Faro, S | 4 |
| Sweet, RL | 6 |
| Ledger, WJ | 1 |
| Berkeley, AS | 1 |
| Eschenbach, DA | 1 |
| Wölner-Hanssen, P | 1 |
| Pastorek, JG | 1 |
| Dodson, MG | 1 |
| McGregor, JA | 2 |
| Crombleholme, WR | 3 |
| Newton, E | 1 |
| Tuomala, R | 1 |
| Ovalle, A | 1 |
| Martínez, MA | 1 |
| Casals, A | 1 |
| Yuhaniak, R | 1 |
| Giglio, MS | 1 |
| Roy, S | 1 |
| O'Brien, WF | 1 |
| Sanfilippo, JS | 1 |
| Seidlin, M | 1 |
| Martens, MG | 2 |
| Gall, S | 1 |
| Reljic, M | 1 |
| Gorisek, B | 1 |
| Tepper, R | 1 |
| Aviram, R | 1 |
| Cohen, N | 1 |
| Cohen, I | 1 |
| Holtzinger, M | 1 |
| Beyth, Y | 1 |
| Stoĭkov, S | 1 |
| Popov, I | 1 |
| Soper, DE | 1 |
| Schnider, G | 1 |
| Birken, RA | 1 |
| Poindexter, AN | 1 |
| Kliment, L | 1 |
| Kvĕton, J | 1 |
| Hatala, X | 1 |
| Uri, FI | 1 |
| Sartawi, SA | 1 |
| Dajani, YF | 1 |
| Masoud, AA | 1 |
| Barakat, HF | 1 |
| Letterie, GS | 1 |
| Monif, GR | 1 |
| Osborne, NG | 1 |
| Thadepalli, H | 1 |
| Mathai, D | 1 |
| Scotti, R | 1 |
| Bansal, MB | 1 |
| Savage, E | 1 |
| Sesti, F | 1 |
| Farnè, C | 1 |
| Piccione, E | 1 |
| Walters, MD | 1 |
| Hammill, H | 1 |
| Maccato, M | 1 |
| Riddle, GD | 1 |
| LaPread, E | 1 |
| Schachter, J | 2 |
| Ohm-Smith, M | 2 |
| Luft, J | 1 |
| Whidden, R | 1 |
| Acar, B | 1 |
| Zissis, NP | 1 |
| Landers, DV | 1 |
| Crombleholme, W | 1 |
| Landers, D | 1 |
| Robbie, MO | 1 |
| Hadley, WK | 1 |
| DeKay, V | 1 |
| Dahrouge, D | 1 |
| Gunning, J | 1 |
| Hemsell, PG | 1 |
| Heard, MC | 1 |
| Nobles, BJ | 1 |
| Ciraru-Vigneron, N | 1 |
| Bercau, G | 1 |
| Sauvanet, E | 1 |
| Nguyen Tan Lung, R | 1 |
| Felten, A | 1 |
| Leaute, JB | 1 |
| Zylbertrest, T | 1 |
| Barrier, J | 1 |
| Lebceuf, D | 1 |
| Rousset, D | 1 |
| Cacault, JA | 1 |
| Engelman, P | 1 |
| Larsen, JW | 1 |
| Voise, CT | 1 |
| Grossman, JH | 1 |
| Forster, GE | 1 |
| Munday, PE | 1 |
| Lazebnik, N | 1 |
| Noy, S | 1 |
| Lazebnik, R | 1 |
| Hezroni, Y | 1 |
| Amoday, I | 1 |
| Aviram, A | 1 |
| Dickinson, PC | 1 |
| Saphyakhajon, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized Clinical Trial Between Clindamycin Once and Thrice a Day in Septic Abortion.[NCT02309346] | Phase 4 | 190 participants (Anticipated) | Interventional | 2014-12-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for gentamicin and Pelvic Inflammatory Disease
| Article | Year |
|---|---|
Antibiotic regimens for treating acute pelvic inflammatory disease. An evaluation.
Topics: Acute Disease; Anti-Bacterial Agents; Aztreonam; Cefotetan; Cefoxitin; Chlamydia Infections; Chlamyd | 1994 |
22 trials available for gentamicin and Pelvic Inflammatory Disease
| Article | Year |
|---|---|
Key pharmacokinetic parameters of isepamicin in febrile neutropenic cancer patients and in women with acute pelvic inflammatory disease.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Area Under Curve; Female; Fever; Gentamicins; Hematolog | 2005 |
The microbiology and therapy of acute pelvic inflammatory disease in hospitalized patients.
Topics: Adolescent; Adult; Amoxicillin; Anaerobiosis; Anti-Bacterial Agents; Bacteria; Drug Therapy, Combina | 1980 |
Comparison of three regimens recommended by the Centers for Disease Control and Prevention for the treatment of women hospitalized with acute pelvic inflammatory disease.
Topics: Acute Disease; Adolescent; Adult; Cefotetan; Cefoxitin; Centers for Disease Control and Prevention, | 1994 |
Randomized comparison of ampicillin-sulbactam to cefoxitin and doxycycline or clindamycin and gentamicin in the treatment of pelvic inflammatory disease or endometritis.
Topics: Adult; Ampicillin; Cefoxitin; Clindamycin; Doxycycline; Drug Therapy, Combination; Endometritis; Fem | 1994 |
Piperacillin and tazobactam versus clindamycin and gentamicin in the treatment of hospitalized women with pelvic infection. The Piperacillin/tazobactam Study Group.
Topics: Bacterial Infections; beta-Lactamase Inhibitors; Clindamycin; Drug Administration Schedule; Drug The | 1994 |
A multicenter study comparing intravenous meropenem with clindamycin plus gentamicin for the treatment of acute gynecologic and obstetric pelvic infections in hospitalized women.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Clindamycin; Diarrhea; Dru | 1997 |
C-reactive protein and the treatment of pelvic inflammatory disease.
Topics: Abscess; Adult; Blood Sedimentation; Body Temperature; C-Reactive Protein; Ceftriaxone; Clindamycin; | 1998 |
[The use of the antibiotic cefoxitin (Mefoxin) in gynecological practice].
Topics: Ampicillin; Analysis of Variance; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefoxitin; Cephamyc | 1997 |
A comparison of netilmicin and gentamicin in the treatment of pelvic infections.
Topics: Acute Disease; Adult; Drug Therapy, Combination; Female; Gentamicins; Humans; Netilmicin; Pelvic Inf | 1979 |
Comparative evaluation of clindamycin/gentamicin and cefoxitin/doxycycline for treatment of pelvic inflammatory disease: a multi-center trial. The European Study Group.
Topics: Acute Disease; Adolescent; Adult; Cefoxitin; Clindamycin; Doxycycline; Drug Therapy, Combination; Fe | 1992 |
Ciprofloxacin monotherapy for acute pelvic infections: a comparison with clindamycin plus gentamicin.
Topics: Acute Disease; Adolescent; Adult; Ciprofloxacin; Clindamycin; Drug Therapy, Combination; Female; Gen | 1991 |
A randomized comparison of gentamicin-clindamycin and cefoxitin-doxycycline in the treatment of acute pelvic inflammatory disease.
Topics: Acute Disease; Adult; Bacteria; Cefoxitin; Cervix Uteri; Clindamycin; Doxycycline; Drug Therapy, Com | 1990 |
Comparison of cefotaxime, cefoxitin and clindamycin plus gentamicin in the treatment of uncomplicated and complicated pelvic inflammatory disease.
Topics: Adolescent; Adult; Bacteria; Bacteroides; Cefotaxime; Cefoxitin; Chlamydia trachomatis; Clindamycin; | 1990 |
Efficacy of single-agent therapy for the treatment of acute pelvic inflammatory disease with ciprofloxacin.
Topics: Acute Disease; Adult; Bacteria; Ciprofloxacin; Clindamycin; Drug Therapy, Combination; Female; Genta | 1989 |
Piperacillin alone vs triple antibiotic combination in gynecological infections.
Topics: Adult; Clindamycin; Drug Therapy, Combination; Endometritis; Female; Gentamicins; Humans; Pelvic Inf | 1989 |
Sulbactam/ampicillin versus metronidazole/gentamicin in the treatment of severe pelvic infections.
Topics: Ampicillin; beta-Lactamase Inhibitors; Cellulitis; Drug Therapy, Combination; Endometritis; Female; | 1986 |
A comparison of parenteral sulbactam/ampicillin versus clindamycin/gentamicin in the treatment of pelvic inflammatory disease.
Topics: Ampicillin; beta-Lactamase Inhibitors; Clindamycin; Drug Therapy, Combination; Female; Gentamicins; | 1986 |
Piperacillin and a combination of clindamycin and gentamicin for the treatment of hospital and community acquired acute pelvic infections including pelvic abscess.
Topics: Abscess; Adult; Bacterial Infections; Clindamycin; Clinical Trials as Topic; Costs and Cost Analysis | 1987 |
[The drug combination amoxicillin-clavulanic acid compared to the triple combination ampicillin-gentamicin-metronidazole in the treatment of severe adnexal infections].
Topics: Amoxicillin; Ampicillin; Bacterial Infections; Clavulanic Acid; Clavulanic Acids; Clinical Trials as | 1986 |
[Prospective randomized study comparing the efficacy and tolerance of clindamycin-gentamycin versus metronidazole-gentamycin in acute utero-adnexal infections in hospitalized patients].
Topics: Adolescent; Clindamycin; Clinical Trials as Topic; Drug Therapy, Combination; Endometritis; Female; | 1987 |
Comparison of cefoxitin and clindamycin-gentamicin for pelvic infections.
Topics: Adolescent; Adult; Cefoxitin; Cellulitis; Clindamycin; Drug Therapy, Combination; Endometritis; Fema | 1986 |
Treatment of Bacteroides infection with clindamycin-2-phosphate.
Topics: Abortion, Septic; Abscess; Adolescent; Adult; Aged; Bacteroides Infections; Child; Child, Preschool; | 1974 |
18 other studies available for gentamicin and Pelvic Inflammatory Disease
| Article | Year |
|---|---|
Daily dose of clindamycin versus standard divided doses in obstetrical and gynecological infections: a retrospective cohort study.
Topics: Abortion, Septic; Adult; Anti-Bacterial Agents; Clindamycin; Drug Administration Schedule; Drug Ther | 2013 |
Significantly increased concentration of soluble urokinase-type plasminogen activator receptor in the blood of patients with pelvic inflammatory disease.
Topics: Adult; Anti-Bacterial Agents; Biomarkers; Case-Control Studies; Cephalosporins; Doxycycline; Enzyme- | 2013 |
[Clinical observation on integrated traditional Chinese and Western medicine therapy in treating patients with pelvic inflammatory disease: a report of 28 cases].
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; | 2006 |
Piperacillin versus clindamycin plus gentamicin for pelvic infections.
Topics: Adult; Cesarean Section; Clindamycin; Drug Therapy, Combination; Endometritis; Female; Gentamicins; | 1984 |
[Hypokalemia, hypocalcemia and hypomagnesemia associated with gentamicin].
Topics: Adult; Female; Gentamicins; Humans; Hypocalcemia; Hypokalemia; Magnesium; Pelvic Inflammatory Diseas | 1980 |
Treatment of pelvic inflammatory disease.
Topics: Ampicillin; Female; Gentamicins; Humans; Pelvic Inflammatory Disease; Penicillins | 1980 |
[Treatment of acute pelvic inflammatory diseases with a new antibiotic compound preparation (author's transl)].
Topics: Adolescent; Adult; Ampicillin; Cervix Mucus; Dicloxacillin; Drug Combinations; Drug Therapy, Combina | 1980 |
[Clinical and microbiological study of acute pelvic inflammatory disease].
Topics: Abdomen; Acute Disease; Adolescent; Adult; Bacteria; Cervix Uteri; Chloramphenicol; Female; Gentamic | 1993 |
Doppler flow characteristics in patients with pelvic inflammatory disease: responders versus nonresponders to therapy.
Topics: Adnexa Uteri; Adult; Amoxicillin; Case-Control Studies; Clavulanic Acid; Drug Therapy, Combination; | 1998 |
Once-daily dosing of gentamicin.
Topics: Female; Gentamicins; Humans; Pelvic Inflammatory Disease | 1998 |
[Sisomicin in the management of gynecologic inflammations (proceedings)].
Topics: Adult; Female; Gentamicins; Humans; Pelvic Inflammatory Disease; Sisomicin; Uterine Cervicitis | 1978 |
Amoxycillin/clavulanic acid (augmentin) compared with triple drug therapy for pelvic inflammatory disease.
Topics: Administration, Oral; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; | 1992 |
Serum gentamicin concentrations in postpartum endomyometritis.
Topics: Adult; Case-Control Studies; Cellulitis; Endometritis; Female; Gentamicins; Humans; Pelvic Inflammat | 1992 |
Ciprofloxacin monotherapy for acute pelvic infections: a comparison with clindamycin plus gentamicin.
Topics: Bacterial Infections; Ciprofloxacin; Clindamycin; Female; Gentamicins; Humans; Pelvic Inflammatory D | 1992 |
[Medical treatment of pelvic inflammatory disease. A clinical study on the therapeutic effectiveness of piperacillin + erythromycin and of piperacillin + clindamycin + gentamycin].
Topics: Clindamycin; Drug Evaluation; Drug Therapy, Combination; Erythromycin; Female; Gentamicins; Hospital | 1990 |
Sulbactam/ampicillin in the treatment of acute pelvic inflammatory disease.
Topics: Adult; Ampicillin; Bacteria, Aerobic; Bacteria, Anaerobic; Cefoxitin; Doxycycline; Drug Therapy, Com | 1989 |
Piperacillin versus clindamycin plus gentamicin.
Topics: Bacterial Infections; Clindamycin; Female; Gentamicins; Humans; Pelvic Inflammatory Disease; Piperac | 1985 |
Gentamicin serum half-life: a comparison between pregnant and non-pregnant women.
Topics: Adult; Creatinine; Female; Fetal Membranes, Premature Rupture; Gentamicins; Half-Life; Humans; Pelvi | 1985 |